Our News on Newswise

Newswise: 673b6ea12009b_6e40eae1-324c-4875-b674-026ecf111593.jpg

Maryland Professor Luana Colloca Recognized with Lifetime Achievement Award

The National Italian American Foundation (NIAF) and the Sbarro Health Research Organization (SHRO) named Dr. Luana Colloca the recipient of the 2024 Giovan Giacomo Giordano-NIAF Lifetime Achievement Award for Ethics and Creativity in Medical...
18-Nov-2024 10:55 AM EST Add to Favorites

Personalized Breast Cancer Treatment through Non-Invasive Liquid Biopsy

In patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer, the molecular classification of their case plays a pivotal role in the formulation of personalized treatment plans aimed at optimizing outcomes. Despite notable...
14-Nov-2024 1:35 PM EST Add to Favorites

Chili Peppers Exhibit Antitumor Effect on Mesothelioma Cancer Cells

Capsaicin, the compound in chili peppers which gives them their spicy taste, may become a source of new, natural drugs for the hard-to-treat Mesothelioma type of cancer.
5-Nov-2024 12:55 PM EST Add to Favorites

Newswise: 6720e68739073_NIH-SHRO.jpg

NIH Director Monica M. Bertagnolli Honored with NIAF Leonardo da Vinci Award in Health and Science

The National Italian American Foundation (NIAF) presented its Leonardo da Vinci Award in Health and Science to National Institutes of Health (NIH) Director Monica M. Bertagnolli Saturday at the 49th annual NIAF gala in Washington, D.C.
29-Oct-2024 9:35 AM EDT Add to Favorites

Newswise: 66fbfaa939b68_niaf2024.jpg

SHRO Hosts Scientific Session at the National Italian-American Foundation Gala in Washington D.C

On October 26, 2024, the National Italian-American Foundation (NIAF) will hold its 49th annual Gala at the Omni Shoreham Hotel in Washington D.C. As part of the weekend's prestigious events, the Sbarro Health Research Organization (SHRO) will host a...
1-Oct-2024 9:05 AM EDT Add to Favorites

Understanding Cancer Patients with Malnutrition and Metabolic Dysfunction

Cancer patients frequently experience metabolic dysfunction leading to severe weight loss correlating with a poor prognosis. Causes for this dysfunction include malnutrition and cachexia, a systemic inflammation affecting brain mechanisms regulating...
17-Sep-2024 8:05 AM EDT Add to Favorites

Newswise: 66e1a94ca6532_SHRO.png

PA State Senator Aument Recognized for His Support of Research at SHRO

Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine has benefited from the support of Pennsylvania State Sen. Ryan Aument since he took office in 2014.
11-Sep-2024 10:05 AM EDT Add to Favorites

Newswise: 66e1a65414f57_Migration.png

Migrant Women and Access to Sexual and Reproductive Health Services

The number of people living in a different place from their place of birth is increasing year by year. Although women have always been involved in migratory movements, today they are increasingly doing so independently. Women are migrating from the...
11-Sep-2024 10:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert

COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST

Newswise: Slide1.jpg

Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT

Newswise: giordanoheadshot.png

Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST

See All Experts

About

Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.

Experts

close
0.53935